• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cord Blood Registry, U.S. Women's Health Alliance partner

Cord Blood Registry, U.S. Women's Health Alliance partner

December 4, 2013
CenterWatch Staff

Cord Blood Registry (CBR), a newborn stem cell company, and the U.S. Women's Health Alliance have partnered on a nationwide patient education and quality initiative to ensure all expectant parents understand their options regarding umbilical cord stem cell collection and possibly improve medical outcomes for their families.

Together, the Alliance and CBR will educate parents on umbilical cord and tissue banking options and advance clinical research by screening for high-risk pregnancies and families pre-diagnosed with a condition that might benefit from participating in CBR's Newborn Possibilities Program, which provides free cord blood and cord tissue processing and five years of storage to qualifying families. The Alliance and CBR also will collaborate to improve the quality of cord blood collections to maximize the number of cells collected and minimize contamination.

"Our mission is to promote high-quality, affordable healthcare through collaboration with doctors, insurance companies, hospitals, government and private industry," said Jack Feltz, M.D, president of the U.S. Women's Health Alliance. 

"Many expectant parents are unaware of the value that umbilical cord blood stem cells may offer to the advancement of medicine and potentially, to their own family's health. As a result, most newborn stem cells are discarded as medical waste," says Geoff Crouse, CEO of Cord Blood Registry. "Stem cells found in the umbilical cord play a vital role in advancing regenerative medicine, and have the potential to revolutionize treatment for many conditions in the future.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing